Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ.
Sign Up to like & getrecommendations! Published in 2021 at "Lung cancer"
DOI: 10.1016/j.lungcan.2021.05.028
Abstract: INTRODUCTION Carcinoma in situ is a rare non-invasive histology of non-small cell lung cancer (NSCLC) with excellent survival outcomes with resection. However, management of lung biopsy suggestive of in situ disease remains unclear. To inform… read more here.
Keywords: biopsy suggestive; carcinoma situ; disease; invasive disease ... See more keywords